Recruiting
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
About this study
Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.
- Condition
- Cutaneous T Cell Lymphoma
- Sponsor
- Northwestern University
Who can join
- Age
- 18 to 89 years
- Sex
- All sexes
- Healthy volunteers
- Accepted
Inclusion 11
- Minimum age: 18 years
- Maximum age: 89 years
- Study condition: Cutaneous T Cell Lymphoma
- Group 1: Patients with stage IA-IIA cutaneous T cell lymphoma
- Group 2: Patients with stage IIB and above cutaneous T cell lymphoma
- Group 3: Patients with CD30+ lymphoproliferative disorder including lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma
- Group 4: Patients with plaque psoriasis with BSA\>5% on routine phototherapy per standard of care
- Group 5: Patients with moderate to severe atopic dermatitis on routine bleach bath therapy per standard of care
- Group 6: Healthy individuals without the above skin conditions, similar age and sex distribution to the patients with cutaneous T cell lymphoma
- All Groups: subjects who are age 18-89 years of age at time of enrollment
- All Groups: Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443).
Exclusion 4
- All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
- All Groups: Subjects who are unable to give consent
- Patients currently on systemic antibiotics or recent (within past 4 weeks) exposure to systemic antibiotics
- We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.
Where
1 site, 1 recruiting
Northwestern University
Chicago, Illinois, United States
Contact
-
Dermatology CTU
312-503-5944 NUderm-research@northwestern.edu
Potential match only. Final eligibility is determined by the study team.